Tyra Biosciences, Inc.
- TYRA
- NASDAQ
- Biotechnology
- Oncology Biotech
- FGFR Inhibitors
$18.66
Today +0.74%Quote Oct 19, 2026, 01:55 PM UTC
−24.19%over the last month
Max drawdown −28.0%From 1-month high −28.0%3 months −40.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.11B
Quote Oct 19
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$43.40
+132.6% from here
Floor
$18.63
0.2% below price
Where the price sits
7 analysts
Analyst range, low to high
$29.00$56.00
- Price $18.66
- Resistance $19.28
- Consensus $43.40
The price is just above its floor. Analysts' average target sits about 133% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TYRAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
87
Founded
2018